{"url":"https://lda.senate.gov/api/v1/filings/cb4128ce-dfdf-43be-b05d-c46bede46be2/","filing_uuid":"cb4128ce-dfdf-43be-b05d-c46bede46be2","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2023,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cb4128ce-dfdf-43be-b05d-c46bede46be2/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Julie Pawelczyk","dt_posted":"2023-10-20T10:30:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 Pennsylvania Ave, NW","registrant_address_2":"13th Floor North","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401004840,"url":"https://lda.senate.gov/api/v1/registrants/401004840/","house_registrant_id":null,"name":"THE CONAFAY GROUP, LLC","description":"Life Sciences Consulting Firm","address_1":"1001 Pennsylvania Ave, NW","address_2":"13th Floor North","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERICA WOODWARD","contact_telephone":"+1 859-229-7237","dt_updated":"2026-01-30T10:00:55.918324-05:00"},"client":{"id":51201,"url":"https://lda.senate.gov/api/v1/clients/51201/","client_id":51201,"name":"VAXXAS INC","general_description":"Vaccine Research","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-04-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Support for vaccination technology.","foreign_entity_issues":"Vaxxas Pty Ltd","lobbyists":[{"lobbyist":{"id":64541,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"P.","last_name":"PAWELCZYK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139395,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTEN","nickname":null,"middle_name":null,"last_name":"LAFAYETTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}